Trade names PTZ-601 ChemSpider 9168406 3D model (Jmol) Interactive image Route Intravenous therapy | Routes of
administration IV Formula C18H21N3O4S2 Molar mass 407.51 g/mol | |
 | ||
Legal status US: Investigational New Drug | ||
Razupenem (PTZ-601) is a broad spectrum injectable antibiotic, from the carbapenem subgroup of beta-lactam antibiotics. It was developed as a replacement drug to combat bacteria that had acquired antibiotic resistance to commonly used antibiotics. Razupenem performed well against a variety of bacterial strains, but further development is in doubt due to a high rate of side effects in Phase II clinical trials.
References
Razupenem Wikipedia(Text) CC BY-SA